NCB5OR Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of NCB5OR monoclonal antibodies for investigating NCB5OR protein function. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).NCB5OR, or NADH-cytochrome b5 reductase, is a crucial enzyme involved in electron transport and lipid metabolism. NCB5OR plays a significant role in the reduction of methemoglobin to hemoglobin, thereby maintaining proper oxygen transport in the blood. Additionally, NCB5OR is implicated in the metabolism of various drugs and xenobiotics, making it an important target for studies related to pharmacology and toxicology. Research has shown that NCB5OR expression varies across different tissues and cell types, suggesting diverse physiological functions. Understanding NCB5OR regulation and activity is essential for developing new therapeutic strategies for blood disorders and metabolic diseases. Recent studies have highlighted NCB5OR's potential involvement in diabetes and insulin resistance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of NCB5OR's role in human health and disease.